CASI Pharmaceuticals Ratios (2021-2025) | CASI

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Dec2024 Mar2025 Jun2025
Profitability
Gross Margin 58.77%58.75%58.42%107.10%59.53%59.41%58.72%59.05%52.98%51.95%58.00%49.29%
EBT Margin -77.09%-74.75%-56.10%-145.03%-86.41%-95.16%-55.83%-48.01%-267.85%-212.72%-161.94%-259.54%
EBIT Margin -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-166.33%-266.47%
EBITDA Margin -90.33%-129.05%-79.80%702.86%-67.49%-124.71%-52.47%725.84%276.68%-182.99%-179.55%-320.65%
Operating Margin -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-166.33%-266.47%
Net Margin -77.09%-74.75%-56.10%-475.48%-86.41%-95.98%-55.83%-48.01%-267.85%-212.72%-161.94%-259.54%
Efficiency
Inventory Average 7.95B7.31B7.31B2.08B2.08B
Assets Average 0.07B0.03B0.03B0.03B0.02B
Invested Capital 0.08B0.04B32.23B0.02B0.02B
Asset Utilization Ratio 0.430.800.530.510.92
Leverage & Solvency
Interest Coverage Ratio 49.2446.2652.6945.59
Debt to Equity 0.160.27781.929.93
Debt Ratio 0.100.12251.040.320.00B0.34
Equity Ratio 0.610.460.00B0.320.03
Times Interest Earned 49.2446.2652.6945.59
Valuation
Enterprise Value -0.03B-0.03B-19.85B-0.03B-0.01B-0.00B-0.01B-0.00B-0.01B
Return Ratios
Return on Sales -0.77%-0.75%-0.56%-1.45%-0.86%-0.96%-0.56%-0.48%-2.68%-2.13%-1.47%-1.62%-2.60%
Return on Capital Employed -0.47%0.00%0.00%1.80%
Return on Assets -0.40%-0.89%-0.78%-1.03%-1.88%